Graham Capital Management, L.P. Bridge Bio Pharma, Inc. Transaction History
Graham Capital Management, L.P.
- $3.11 Billion
- Q2 2024
A detailed history of Graham Capital Management, L.P. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 16,709 shares of BBIO stock, worth $446,631. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,709
Previous 387,100
95.68%
Holding current value
$446,631
Previous $12 Million
96.47%
% of portfolio
0.01%
Previous 0.34%
Shares
5 transactions
Others Institutions Holding BBIO
# of Institutions
292Shares Held
175MCall Options Held
8.66MPut Options Held
2.76M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY31.1MShares$830 Million45.4% of portfolio
-
Viking Global Investors LP25.1MShares$671 Million2.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$376 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$333 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$162 Million67.33% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.96B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...